Menu
Back to User profile » Dr Yusuf S Althobaiti
Papers published by Dr Yusuf S Althobaiti:
Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment [Retraction]
Ullah A, Al Kury LT, Althobaiti YS, Ali T, Shah FA
Journal of Inflammation Research 2022, 15:6065-6066
Published Date: 4 November 2022
RETRACTED ARTICLE: Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment
Ullah A, Al Kury LT, Althobaiti YS, Ali T, Shah FA
Journal of Inflammation Research 2022, 15:3873-3890
Published Date: 11 July 2022
Reduction of Hepatic Steatosis, Oxidative Stress, Inflammation, Ballooning and Insulin Resistance After Therapy with Safranal in NAFLD Animal Model: A New Approach
Sabir U, Irfan HM, Alamgeer, Ullah A, S Althobaiti Y, Asim MH
Journal of Inflammation Research 2022, 15:1293-1316
Published Date: 24 February 2022
Investigation of 1, 3, 4 Oxadiazole Derivative in PTZ-Induced Neurodegeneration: A Simulation and Molecular Approach
Faheem M, Althobaiti YS, Khan AW, Ullah A, Ali SH, Ilyas U
Journal of Inflammation Research 2021, 14:5659-5679
Published Date: 1 November 2021
Short- and Long-Term Effects of Vitamin D Treatment on Bacillus Calmette-Guerin-Induced Depressive-Like Behavior in Mice
Saleh LA, Almutairi FM, Alorabi WK, Alkuhayli BA, Alzaidi SS, Alzahrani SB, Aljumayi FA, Abduljabbar MH, Alharthi AS, Alsufyani MA, Alhazmi MH, Althobaiti AA, Almutairi FN, Alshehri FS, Altowairqi E, Althobaiti YS
Neuropsychiatric Disease and Treatment 2021, 17:711-720
Published Date: 2 March 2021